Burning Rock Biotech Limited (BNR) Tops Q3 EPS by 147c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q3 EPS of (RMB0.31), RMB1.47 better than the analyst estimate of (RMB1.78). Revenue for the quarter came in at RMB21.74 million versus the consensus estimate of RMB156 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Medtronic jumps on earnings beat and raised guidance
• Citi opens downside catalyst watch on Kroger as Walmart price war intensifies
• S&P Global completes acquisition of datacenterHawk